AFP and hepatocellular carcinoma: As another possible limitation, we did not assess the performance of other valuable models, such as those that include HCC serological biomarkers as covariates [30]; since biomarkers, including AFP, are not universally recommended for the surveillance of patients at risk of HCC development, we deliberately chose to investigate only NSS, including variables routinely collected during standard clinical practice.